Fig. 1: First line treatment.
Drugs and combinations used for first-line treatment in patients included in the study. IMiD immunomodulatory drug, PI proteasome inhibitor.
Fig. 1: First line treatment. | Blood Cancer Journal
Drugs and combinations used for first-line treatment in patients included in the study. IMiD immunomodulatory drug, PI proteasome inhibitor.
